Literature DB >> 3579712

Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors.

J M Seddon, L Polivogianis, C C Hsieh, D M Albert, J W Gamel, E S Gragoudas.   

Abstract

Criteria for the Callender classification of uveal melanoma are subjective and lead to variations among observers of the same tumor. Two other measures for cell type-the number of epithelioid cells per high-power field (Epi/HPF) and the inverse SD of nucleolar area (ISDNA)-were evaluated as prognostic factors for survival following enucleation for uveal melanoma in 232 patients. Variables significantly related to the number of Epi/HPF were related to ISDNA. Larger, more anteriorly located tumors had a high number of Epi/HPF and a low ISDNA. The two measures were also correlated. Using Kaplan-Meier survival analysis, both measures were related to tumor deaths. Worse prognosis was associated with a higher number of Epi/HPF and a lower ISDNA. Considered together in Cox' proportional hazards analysis, both measures independently predicted outcome. Separately, each measure predicted uveal melanoma-related deaths, in combination with largest tumor dimension, invasion of tumor to the line of transection, and location of the anterior tumor margin. Although ISDNA is the more objective measure of cell type, its practicality compared with other measures of cell type must also be considered.

Entities:  

Mesh:

Year:  1987        PMID: 3579712     DOI: 10.1001/archopht.1987.01060060087039

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  18 in total

Review 1.  Eye cancer: unique insights into oncogenesis: the Cogan Lecture.

Authors:  J William Harbour
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  DNA ploidy pattern in choroidal melanoma: correlation with survival. A flow cytometry study on archival material.

Authors:  P Toti; G Greco; P Mangiavacchi; A Bruni; M L Palmeri; P Luzi
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

3.  Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.

Authors:  Ahmad Al-Moujahed; Fotini Nicolaou; Katarzyna Brodowska; Thanos D Papakostas; Anna Marmalidou; Bruce R Ksander; Joan W Miller; Evangelos Gragoudas; Demetrios G Vavvas
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-29       Impact factor: 4.799

4.  Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.

Authors:  C Chiquet; J D Grange; L Ayzac; P Chauvel; L M Patricot; M Devouassoux-Shisheboran
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

5.  Metastasis of malignant melanoma of the choroid and ciliary body to the contralateral choroid.

Authors:  J Li; K Resnick; M Tso
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-09       Impact factor: 3.117

6.  Uveal melanoma: molecular pattern, clinical features, and radiation response.

Authors:  Michael C Chappell; Devron H Char; Tia B Cole; J William Harbour; Kavita Mishra; Vivian K Weinberg; Theodore L Phillips
Journal:  Am J Ophthalmol       Date:  2012-04-27       Impact factor: 5.258

7.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

8.  Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.

Authors:  H Klaus; P K Lommatzsch; U Fuchs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

9.  DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation.

Authors:  C Mooy; K Vissers; G Luyten; A Mulder; T Stijnen; P de Jong; F Bosman
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638

Review 10.  Emerging insights into the molecular pathogenesis of uveal melanoma.

Authors:  Solange Landreville; Olga A Agapova; J William Harbour
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.